Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry - Image 1

£65.63

VDM Verlag Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

Name: Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry
Brand: VDM Verlag
Price: 65.63 GBP
Availability: InStock

Pharmacology

This is the usual price. Wait for it to drop, or tell us your number.

£66 today · usual range £0–£0 · best ever £62

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 633 days • 633 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 633 days • 7 price levels

Days at Price

Current Price

Price Analysis

Most common price: £70 (312 days, 49.3%)

Price range: £62 - £72

Price levels: 7 different prices over 633 days

Description

The research is based upon my Wharton thesis, focuses on pharmaceutical R&D investment decision. It is organized into 1 theoretical chapter, 4 empirical chapters and 3 empirical appendices. Chapter2 develops a q-model framework for analyzing the determinants of pharmaceutical R&D investment. Chapters 3 and 4 test the capital market imperfections hypothesis using a variety of statistical methods. Chapter 5 builds upon this work and test the hypothesis that pharmaceutical price regulation diminishes incentives to invest in R&D. Finally, Chapter 6 employs a computer simulation model of pharmaceutical innovation and competition to study how price regulation in U.S. could affect R&D investment and innovation. Results reveal cash flows are an independent determinant of pharmaceutical R&D investment. Evidence was also uncovered suggesting pharmaceutical price regulation exerts a substantially negative influence on firm R&D investment intensity. Chapter Six obtains results consistent with those reported in Chapter Five, but given the simulation technique and investment strategy perspective numerous other results and findings were obtained.

Product Specifications

Brand: VDM Verlag
Format: Paperback
ASIN: 3639095979
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Pharmacology
Domain: Amazon UK
Release Date: 15 March 2010
Listed Since: 18 March 2010

Barcode

No barcode data available

VDM Verlag Economics of Drug R&D:Financing, Strategic and Policy Considerations; Price Regulation,Capital Market Imperfections and Strategic R&D Investment Behavior in the Pharmaceutical Industry

This is the usual price. Wait for it to drop, or tell us your number.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Pharmaceutical Innovation, Competition and Patent Law: A Trilateral Perspective

Routledge Pharmaceutical Industry and Public Policy in India

Economics of the Pharmaceutical and Medical Device Industry: Supply Chain, Trade and Innovation (Routledge Studies in the Economics of Innovation)

Global Pharmaceutical Policy: Ensuring Medicines for Tomorrow’s World

Optimization of Pharmaceutical R&D Programs and Portfolios: Design and Investment Strategy

Springer - Innovation and Marketing in Pharmaceutical Industry

Fundamentals of Drug Development

Darwin's Medicine: How Business Models in the Life Sciences Industry are Evolving

Competition Law and Policy in the Japanese Pharmaceutical Sector (Kobe University Monograph Series in Social Science Research)

Global New Drug Development: An Introduction (ULLA Series in Pharmaceutical Sciences)

Evergreening Patent Exclusivity in Pharmaceutical Products: Supplementary Protection Certificates, Orphan Drugs, Paediatric Extensions and ATMPs

Boosting Pharmaceutical Innovation in the Post-TRIPS Era: Real-Life Lessons for the Developing World

EU Law of Competition and Trade in the Pharmaceutical Sector (Elgar Competition Law and Practice series)

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

Pharmaceuticals, Corporate Crime and Public Health

The Public Financing of Pharmaceuticals: An Economic Approach

Value Creation in the Pharmaceutical Industry: The Critical Path to Innovation

World Pharmaceutical Industry

Real Options and Intellectual Property: Capital Budgeting Under Imperfect Patent Protection: 587 (Lecture Notes in Economics and Mathematical Systems, 587)

Research and Development in the Pharmaceutical Industry

Pharmaceutical Product Development: Insights Into Pharmaceutical Processes, Management and Regulatory Affairs

The Pharmaceutical Industry: A Guide to Historical Records (Studies in British Business Archives)

Pharmaceutical Economics (The International Library of Critical Writings in Economics series)

Regulatory Protection in the Pharmaceutical and Life Science Industries: Challenges, Opportunities and Ongoing Reform (Elgar Monographs in Intellectual Property Law)